Is it now time to prepare psychiatry for a psychedelic future?
Where this comes from
- Record sourced from PubMed, PMID 38764044.
- Also identified by DOI 10.1192/bjp.2024.76.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Australia has just rescheduled two drugs controlled under the United Nations Psychotropic Drug Conventions, psilocybin and MDMA, as treatments for treatment-resistant depression and post-traumatic stress disorder respectively. This feature explores the reasons for these developments, the opportunities and challenges they provide to psychiatry communities and how along with health systems these communities might respond to these developments.
Medical subject headings
- Hallucinogens
- Psilocybin
- Psychiatry
- Stress Disorders, Post-Traumatic